TerminatedPhase 1

Comparison of Once Daily 40 mg Torsemide With Twice-daily 40 mg Furosemide

Stopped: recruitment issues

India20 participantsStarted 2021-06-30

Plain-language summary

To compare the effects of 40 mg once-daily Torsemide ER to 40 mg twice daily Furosemide on 24-hour sodium excretion.

Who can participate

Age range18 Years – 70 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients of either gender over 18 years of age with clinical diagnosis of CHF and on a stable dose of 40 mg Furosemide. Exclusion Criteria: * Requirement for any other diuretic, history of cardiac dysrhythmia, other concurrent cardiovascular illness.

What they're measuring

change in 24-hour sodium excretion compared to baseline

Timeframe: 24 hours

Trial details

NCT IDNCT03509545

SponsorSarfez Pharmaceuticals, Inc.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2022-06-30

View on ClinicalTrials.gov More Body Weight Changes trials